01 /What it is
LL-37 is the active 37-amino acid C terminal fragment of the human cathelicidin antimicrobial peptide precursor hCAP18.
02 /How it works
In research models, LL-37 is studied as a host defense peptide active across multiple microbial research models, with additional research interest in immune modulation pathways.
03 /What researchers explore it for
Researchers have explored LL-37 in antimicrobial pathway research, in immune modulation research, and in wound research models.
04 /Safety and interactions
LL-37 is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Peptide family: cathelicidin derived antimicrobial peptides. The Apothify library lists LL-37 for encyclopedia coverage only.
